Skip to content
Achilles Neurology

Demyelinating Diseases: Types, Symptoms, and Why Demyelination Does Not Always Mean MS

Medically reviewed by Dr. Achillefs Ntranos, MDPublished September 14, 2024Updated October 9, 2026
A woman looking at a brain illustration beside two myelinated nerve fibers.

Demyelinating diseases damage myelin, the insulation around nerve fibers, so nerve signals slow down or stop. Most can be treated. Multiple sclerosis is the most common, and it has its own page; this one covers the whole group and how a neurologist tells them apart, including the conditions mistaken for MS at first: neuromyelitis optica, MOG antibody disease, transverse myelitis, and ADEM. Getting the label right matters, because the treatments differ and some MS drugs make the others worse.

What demyelination is

Myelin insulates nerve fibers in the central nervous system and lets electrical signals travel quickly. Damage it and the signals slow or stop, producing a symptom that depends on where the damage happened: the optic nerve, the spinal cord, the brainstem, or the brain.

In most of these diseases the immune system does the damage, which is why they overlap with autoimmune neurological conditions. Less often myelin is damaged by infection, by a vitamin or metabolic problem, or by a toxin, and ruling those out is part of the workup.

Two nerve fibers with continuous axons, one with intact myelin and one with patchy myelin.

How myelin supports nerve signals

  • Insulation: Myelin forms a protective covering around nerve fibers.
  • Demyelination: Inflammation can damage that covering.
  • Diagnosis: The cause is identified from the clinical picture and selected tests.
Myelin insulates nerve fibers. Damage to this covering can disrupt communication.

Demyelination symptoms

The symptoms are shared across the group, because they depend on where the myelin was damaged rather than on which disease damaged it:

  • Vision. Dim or blurred vision in one eye, often with pain on eye movement, or double vision.
  • Sensation. Numbness or tingling in a limb, one side of the face, or a band of tightness around the trunk.
  • Strength and walking. Weakness or stiffness, usually in the legs, and unsteadiness.
  • Bladder and bowel. Urgency, difficulty emptying, or constipation, often with numbness below a level on the trunk.
  • Energy and thinking. Fatigue that rest does not fix and brain fog.

The timing is as telling as the symptom. An attack builds over hours to days and lasts at least a day. Symptoms that come and go over seconds or minutes usually have a different cause.

Labeled comparison of intact and damaged myelin around continuous nerve fibers. Arrows distinguish myelin, the axon, damaged myelin, and a normal short gap.

What changes when myelin is damaged

  1. Myelin

    An insulating covering around many nerve fibers. Short gaps between its segments are normal.

  2. Nerve fiber (axon)

    The fiber inside carries electrical messages. The covering and the fiber are different structures.

  3. Damaged myelin

    Loss of this covering can slow or block signals. In MS, the nerve fiber itself can also be injured.

Where the damage occurs helps explain which symptoms appear.

Types of demyelinating diseases

Demyelinating diseases fall into two groups: those of the brain, spinal cord and optic nerves, and those of the nerves outside the brain and spinal cord. Most are immune attacks. A few come from a deficiency, an infection, a too-rapid change in blood sodium or an inherited condition.

Brain, spinal cord, and optic nerves

TypeWhat it is
Multiple sclerosisThe most common. Repeated immune attacks on myelin in the brain, spinal cord and optic nerves
NMOSD (neuromyelitis optica)An antibody disease (aquaporin-4) with severe attacks on the optic nerves and spinal cord
MOGAD (MOG antibody disease)An antibody disease (MOG) that causes optic neuritis, myelitis and, in children, brain inflammation
Transverse myelitisInflammation of the spinal cord, on its own or as the first attack of one of the diseases above
ADEMA single, widespread attack on the brain and spinal cord, usually after an infection
Optic neuritisInflammation of the optic nerve, sometimes a single event and sometimes the first sign of one of the diseases above
Vitamin B12 or copper deficiencyNot immune. A shortage that damages myelin, mostly in the spinal cord, found with blood tests
PML (progressive multifocal leukoencephalopathy)Not immune. A rare brain infection by the JC virus when the immune system is weakened, including by some MS drugs
Osmotic demyelinationNot immune. Damage, mostly in the brainstem, when a very low blood sodium level is corrected too quickly
LeukodystrophiesNot immune. Rare inherited conditions in which myelin does not form or does not last, found with MRI and genetic testing

Peripheral nerves

TypeWhat it is
Guillain-Barré syndromeAn immune attack on the nerves that builds over days, often after an infection
CIDPThe slower counterpart of Guillain-Barré, relapsing or progressing over months
Charcot-Marie-Tooth diseaseThe most common inherited neuropathy. Its most common form damages myelin

How MS, NMOSD, and MOGAD differ

Multiple sclerosisNMOSDMOGAD
Antibody testNone. Diagnosed on MRI and clinical patternAquaporin-4MOG
Typical attackOptic neuritis in one eye, or a sensory or motor relapseSevere optic neuritis, often both eyes, and spinal cord attacksOptic neuritis with a swollen optic disc, myelitis, brain inflammation in children
MRI patternMany small lesions in typical brain locations, short cord lesionsLong cord lesions spanning three or more segmentsFluffy brain lesions, long cord lesions, swollen optic nerves
Spinal fluidOligoclonal bands, a sign of immune activity in the nervous system, usually presentBands usually absentBands usually absent
CourseRelapses, sometimes followed by progressionRelapsing, with more severe attacksSometimes a single event, sometimes relapsing
TreatmentMS disease-modifying therapiesTargeted therapies approved for NMOSDSteroids and immunoglobulin, longer immunotherapy if it relapses

Our side-by-side guide to NMO, MOGAD, and MS goes further into each.

Transverse myelitis is inflammation of the spinal cord itself, causing weakness, a sensory level on the trunk, and bladder problems over hours to days. It can be a one-off, or the first attack of any of the three above, which is why every case needs the full workup. Our guide covers transverse myelitis and its link to MS.

ADEM is a single widespread attack of inflammation in the brain and cord, usually after an infection, most common in children, and usually followed by good recovery.

Isolated optic neuritis can be the first sign of any of these, or can stay a single event. That is why the antibody tests are sent even when the attack seems minor.

Does demyelination always mean MS?

No. The word describes what happened to the myelin, not why. When an MRI report says "demyelination" or "possible demyelinating process", the radiologist is describing how a lesion looks and flagging that MS belongs on the list. It is not a diagnosis of MS.

The inflammatory conditions above are one set of causes. Myelin is also damaged by vitamin B12 or copper deficiency, by some infections, and by toxins, all checked with blood tests. And many white spots called demyelination are not demyelination at all: they are small vessel changes from blood pressure, diabetes, smoking, or age, which radiologists variously call white matter disease, cerebral microangiopathy, or small vessel ischemic change. Migraine leaves similar spots. Our white matter lesions page covers that reading of the report, and our guide to conditions that mimic MS covers the rest.

Demyelination in the peripheral nerves

The nerves outside the brain and spinal cord have their own myelin and their own demyelinating diseases: Guillain-Barré syndrome, which comes on over days after an infection and is treated in hospital because breathing can be affected; CIDP (chronic inflammatory demyelinating polyneuropathy), its slower counterpart; and the inherited Charcot-Marie-Tooth disease. Nerve conduction studies show the slowed signals, sometimes reported as segmental demyelination. These are neuropathies, evaluated with nerve studies rather than brain MRI, and they do not turn into MS. Our guide explains how a neurologist tells neuropathy from MS.

How they are told apart

An autoimmune neurology evaluation answers two questions in order: is this demyelination at all, and if so, which one?

TestWhat it answers
History and examinationWhere the damage is, and whether there were earlier episodes that got dismissed
MRI of brain, cord, and optic nervesThe lesion pattern, which carries most of the weight. Long cord lesions point away from MS
Lumbar punctureOligoclonal bands and inflammatory cells in the spinal fluid
Aquaporin-4 and MOG antibodiesWhich condition. These settle most cases
Blood testsInfection, vitamin deficiency, and systemic autoimmune disease as alternative causes

Why the exact diagnosis matters

Several MS disease-modifying therapies, including interferons, natalizumab, and fingolimod, can trigger severe attacks in people with NMOSD. The specific diagnosis has to be settled before long-term treatment starts, which is why we test for the aquaporin-4 and MOG antibodies in anyone with a first demyelinating event.

Brain and spinal cord model beside blood and spinal-fluid specimen containers.

Finding the cause of demyelination

  • Pattern: The location and appearance of abnormalities matter.
  • Laboratory evidence: Antibody and spinal-fluid tests can help distinguish causes.
  • Diagnosis: Demyelination alone does not establish multiple sclerosis.
MRI findings are interpreted alongside the examination and selected laboratory tests.

Demyelination treatment

None of these is curable yet, and all of them are treatable. The goal is the same across the group: stop the current attack, prevent the next one, and manage what the attacks left behind.

The attack is treated with high-dose corticosteroids, and with plasma exchange when steroids are not enough. Immunoglobulin infusions are used in some conditions, particularly MOGAD.

The next attack is prevented with long-term therapy chosen for the specific diagnosis. This is the step that goes wrong when the diagnosis is wrong.

What is left behind is treated directly: medication for pain, spasticity, fatigue, or bladder problems, physical and occupational therapy, and cognitive rehabilitation when thinking or memory is affected. Rehabilitation does much of the work of recovery.

The body rebuilds some myelin on its own after an attack, which is part of why symptoms improve. Drugs that promote myelin repair are still in trials, so preventing attacks remains the way to protect function.

When to see a neurologist

Promptly, for sudden vision changes especially with pain on eye movement, unexplained weakness, persistent numbness, or a change in bladder or bowel function that lasts more than a day. Rapidly worsening weakness, trouble breathing, or sudden vision loss should go to an emergency department rather than wait for an appointment.

On an MRI report, "demyelination" sounds like a diagnosis, but it describes how a spot looks, not why it is there. An evaluation here starts with a 60-minute first visit with Dr. Ntranos, whose fellowship at Mount Sinai was in multiple sclerosis and demyelinating diseases. He reviews your MRI images himself, explains what they show, and orders the antibody tests and further imaging through your insurance. MRI and any lumbar puncture are arranged at outside facilities and interpreted here, not performed in our office. If you already have a diagnosis and something about it does not fit, we offer second opinions. Follow-ups are usually every one to three months and last 30 to 45 minutes, and messages between visits are answered within 1 business day. Request a visit in Beverly Hills or Los Angeles, or by video anywhere in California; no referral needed, and the office confirms within 1 business day.

Frequently asked questions

References

  1. National Institute of Neurological Disorders and Stroke. Multiple sclerosis.
  2. Cleveland Clinic. Demyelinating disease: what it is, symptoms and treatment.
  3. Wingerchuk DM, et al. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology, 2015.
  4. Banwell B, et al. Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: international MOGAD panel proposed criteria. The Lancet Neurology, 2023.
  5. Consortium of Multiple Sclerosis Centers. Researchers analyze MS life expectancy, survival and mortality in a 60-year study.
  6. Multiple Sclerosis News Today. MS prognosis and life expectancy.
  7. NeurologyLive. Remyelination in multiple sclerosis: progress and pipeline updates.
  8. MedlinePlus, U.S. National Library of Medicine. Multiple sclerosis.

Keep reading

Related pages

Your brain deserves more than fifteen minutes.

Request a visit with Dr. Ntranos, usually the same or next day.